Navamedic ASA Statistics
Total Valuation
Navamedic ASA has a market cap or net worth of NOK 507.29 million. The enterprise value is 621.46 million.
Market Cap | 507.29M |
Enterprise Value | 621.46M |
Important Dates
The last earnings date was Thursday, August 29, 2024.
Earnings Date | Aug 29, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Navamedic ASA has 17.43 million shares outstanding. The number of shares has increased by 2.58% in one year.
Shares Outstanding | 17.43M |
Shares Change (YoY) | +2.58% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 10.92% |
Owned by Institutions (%) | 43.52% |
Float | 12.65M |
Valuation Ratios
The trailing PE ratio is 21.02 and the forward PE ratio is 15.48.
PE Ratio | 21.02 |
Forward PE | 15.48 |
PS Ratio | 0.93 |
PB Ratio | 2.08 |
P/FCF Ratio | 161.76 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.36, with an EV/FCF ratio of 198.17.
EV / Earnings | 25.22 |
EV / Sales | 1.14 |
EV / EBITDA | 9.36 |
EV / EBIT | 12.14 |
EV / FCF | 198.17 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 58.37.
Current Ratio | 1.44 |
Quick Ratio | 0.61 |
Debt / Equity | 58.37 |
Debt / EBITDA | 2.15 |
Debt / FCF | 45.43 |
Interest Coverage | 5.03 |
Financial Efficiency
Return on equity (ROE) is 10.82% and return on invested capital (ROIC) is 8.75%.
Return on Equity (ROE) | 10.82% |
Return on Assets (ROA) | 6.38% |
Return on Capital (ROIC) | 8.75% |
Revenue Per Employee | 12.08M |
Profits Per Employee | 547,533 |
Employee Count | 45 |
Asset Turnover | 1.08 |
Inventory Turnover | 3.60 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.63% in the last 52 weeks. The beta is 0.48, so Navamedic ASA's price volatility has been lower than the market average.
Beta (5Y) | 0.48 |
52-Week Price Change | -9.63% |
50-Day Moving Average | 31.88 |
200-Day Moving Average | 35.03 |
Relative Strength Index (RSI) | 38.02 |
Average Volume (20 Days) | 19,339 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Navamedic ASA had revenue of NOK 543.49 million and earned 24.64 million in profits. Earnings per share was 1.38.
Revenue | 543.49M |
Gross Profit | 217.60M |
Operating Income | 51.20M |
Pretax Income | 34.39M |
Net Income | 24.64M |
EBITDA | 64.01M |
EBIT | 51.20M |
Earnings Per Share (EPS) | 1.38 |
Balance Sheet
The company has 28.32 million in cash and 142.48 million in debt, giving a net cash position of -114.16 million or -6.55 per share.
Cash & Cash Equivalents | 28.32M |
Total Debt | 142.48M |
Net Cash | -114.16M |
Net Cash Per Share | -6.55 |
Equity (Book Value) | 244.10M |
Book Value Per Share | 14.00 |
Working Capital | 88.89M |
Cash Flow
In the last 12 months, operating cash flow was 5.61 million and capital expenditures -2.47 million, giving a free cash flow of 3.14 million.
Operating Cash Flow | 5.61M |
Capital Expenditures | -2.47M |
Free Cash Flow | 3.14M |
FCF Per Share | 0.18 |
Margins
Gross margin is 40.04%, with operating and profit margins of 9.42% and 4.53%.
Gross Margin | 40.04% |
Operating Margin | 9.42% |
Pretax Margin | 6.33% |
Profit Margin | 4.53% |
EBITDA Margin | 11.78% |
EBIT Margin | 9.42% |
FCF Margin | 0.58% |
Dividends & Yields
Navamedic ASA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.58% |
Shareholder Yield | -2.58% |
Earnings Yield | 4.76% |
FCF Yield | 0.62% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |